![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MPPED2 |
Gene summary for MPPED2 |
![]() |
Gene information | Species | Human | Gene symbol | MPPED2 | Gene ID | 744 |
Gene name | metallophosphoesterase domain containing 2 | |
Gene Alias | 239FB | |
Cytomap | 11p14.1 | |
Gene Type | protein-coding | GO ID | GO:0000166 | UniProtAcc | Q15777 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
744 | MPPED2 | AEH-subject1 | Human | Endometrium | AEH | 9.73e-08 | 3.89e-01 | -0.3059 |
744 | MPPED2 | AEH-subject3 | Human | Endometrium | AEH | 1.90e-13 | 5.10e-01 | -0.2576 |
744 | MPPED2 | AEH-subject4 | Human | Endometrium | AEH | 4.11e-13 | 5.86e-01 | -0.2657 |
744 | MPPED2 | AEH-subject5 | Human | Endometrium | AEH | 5.50e-43 | 9.05e-01 | -0.2953 |
744 | MPPED2 | EEC-subject2 | Human | Endometrium | EEC | 3.33e-02 | 2.82e-01 | -0.2607 |
744 | MPPED2 | EEC-subject3 | Human | Endometrium | EEC | 7.36e-03 | -1.84e-01 | -0.2525 |
744 | MPPED2 | EEC-subject4 | Human | Endometrium | EEC | 5.70e-04 | 3.16e-01 | -0.2571 |
744 | MPPED2 | EEC-subject5 | Human | Endometrium | EEC | 2.81e-05 | 3.70e-01 | -0.249 |
744 | MPPED2 | GSM5276934 | Human | Endometrium | EEC | 4.08e-05 | -2.54e-01 | -0.0913 |
744 | MPPED2 | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 1.28e-08 | 9.96e-02 | -0.1917 |
744 | MPPED2 | HCC1 | Human | Liver | HCC | 1.18e-06 | 1.87e+00 | 0.5336 |
744 | MPPED2 | HCC2 | Human | Liver | HCC | 4.66e-04 | 6.98e-01 | 0.5341 |
744 | MPPED2 | S014 | Human | Liver | HCC | 1.34e-13 | 5.26e-01 | 0.2254 |
744 | MPPED2 | S015 | Human | Liver | HCC | 7.91e-13 | 5.45e-01 | 0.2375 |
744 | MPPED2 | S016 | Human | Liver | HCC | 3.16e-19 | 5.77e-01 | 0.2243 |
744 | MPPED2 | GSM5252130_BPH340PrGF_Via | Human | Prostate | BPH | 2.12e-02 | -1.51e-01 | -0.1972 |
744 | MPPED2 | 047563_1562-all-cells | Human | Prostate | BPH | 1.12e-04 | -1.22e-01 | 0.0791 |
744 | MPPED2 | 052095_1628-all-cells | Human | Prostate | BPH | 1.13e-03 | 3.08e-01 | 0.1032 |
744 | MPPED2 | Dong_P1 | Human | Prostate | Tumor | 1.24e-05 | -1.03e-01 | 0.035 |
744 | MPPED2 | Dong_P3 | Human | Prostate | Tumor | 6.28e-26 | 3.67e-01 | 0.0278 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MPPED2 | SNV | Missense_Mutation | c.533N>T | p.Pro178Leu | p.P178L | Q15777 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MPPED2 | SNV | Missense_Mutation | c.73N>T | p.Ala25Ser | p.A25S | Q15777 | protein_coding | deleterious(0.01) | possibly_damaging(0.847) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
MPPED2 | SNV | Missense_Mutation | novel | c.827N>A | p.Thr276Asn | p.T276N | Q15777 | protein_coding | tolerated_low_confidence(0.14) | benign(0.006) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
MPPED2 | SNV | Missense_Mutation | c.5C>T | p.Ala2Val | p.A2V | Q15777 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.985) | TCGA-AX-A0J1-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MPPED2 | SNV | Missense_Mutation | c.786C>G | p.Asp262Glu | p.D262E | Q15777 | protein_coding | deleterious(0) | possibly_damaging(0.859) | TCGA-AX-A2H2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MPPED2 | SNV | Missense_Mutation | novel | c.285N>T | p.Glu95Asp | p.E95D | Q15777 | protein_coding | deleterious(0.03) | probably_damaging(0.951) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
MPPED2 | SNV | Missense_Mutation | c.559N>T | p.Gly187Cys | p.G187C | Q15777 | protein_coding | deleterious(0) | probably_damaging(0.965) | TCGA-AX-A2HF-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | CR | |
MPPED2 | SNV | Missense_Mutation | c.265G>A | p.Glu89Lys | p.E89K | Q15777 | protein_coding | tolerated(0.59) | possibly_damaging(0.787) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
MPPED2 | SNV | Missense_Mutation | novel | c.823N>A | p.Val275Ile | p.V275I | Q15777 | protein_coding | tolerated(0.54) | benign(0) | TCGA-B5-A3FA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MPPED2 | SNV | Missense_Mutation | rs573733258 | c.41N>T | p.Thr14Met | p.T14M | Q15777 | protein_coding | tolerated(0.08) | benign(0.372) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |